These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35052692)

  • 1. Screening of the Promising Direct Thrombin Inhibitors from Haematophagous Organisms. Part I: Recombinant Analogues and Their Antithrombotic Activity In Vitro.
    Kostromina MA; Tukhovskaya EA; Shaykhutdinova ER; Slashcheva GA; Ismailova AM; Palikov VA; Palikova YA; Dyachenko IA; Kravchenko IN; Sadovnikova ES; Novikova NI; Perepechenova NA; Zayats EA; Abramchik YA; Lykoshin DD; Mamaev AN; Grigorieva EV; Momot AP; Murashev AN; Esipov RS
    Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
    Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From haemadin to haemanorm: Synthesis and characterization of full-length haemadin from the leech Haemadipsa sylvestris and of a novel bivalent, highly potent thrombin inhibitor (haemanorm).
    Acquasaliente L; Pierangelini A; Pagotto A; Pozzi N; De Filippis V
    Protein Sci; 2023 Dec; 32(12):e4825. PubMed ID: 37924304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory assays for the evaluation of recombinant hirudin.
    Walenga JM; Hoppensteadt D; Koza M; Wallock M; Pifarre R; Fareed J
    Haemostasis; 1991; 21 Suppl 1():49-63. PubMed ID: 1894197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor.
    Richardson JL; Kröger B; Hoeffken W; Sadler JE; Pereira P; Huber R; Bode W; Fuentes-Prior P
    EMBO J; 2000 Nov; 19(21):5650-60. PubMed ID: 11060016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalirudin: a direct thrombin inhibitor.
    Gladwell TD
    Clin Ther; 2002 Jan; 24(1):38-58. PubMed ID: 11833835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biotechnological production of recombinant analogs of hirudin-1 from Hirudo medicinalis].
    Kostromina MA; Esipov RS; Miroshnikov AI
    Bioorg Khim; 2012; 38(2):166-76. PubMed ID: 22792720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct antithrombins: new perspectives in cardiovascular medicine.
    Lettino M; Toschi V
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jul; 2(3):267-75. PubMed ID: 15320792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of thrombin: relevance to anti-thrombosis strategy.
    Shen GX
    Front Biosci; 2006 Jan; 11():113-20. PubMed ID: 16146717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, sequence analysis, and cloning of haemadin. An anticoagulant peptide from the Indian leech.
    Strube KH; Kröger B; Bialojan S; Otte M; Dodt J
    J Biol Chem; 1993 Apr; 268(12):8590-5. PubMed ID: 8473305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current developments in antithrombotic therapy: the role of antithrombin agents.
    Breddin HK
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():1-8. PubMed ID: 12811005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin.
    Bates SM; Weitz JI
    Am J Cardiol; 1998 Oct; 82(8B):12P-18P. PubMed ID: 9809887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desirudin: a review of its use in the management of thrombotic disorders.
    Matheson AJ; Goa KL
    Drugs; 2000 Sep; 60(3):679-700. PubMed ID: 11030473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
    Carswell CI; Plosker GL
    Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalirudin: a new generation antithrombotic drug.
    Scatena R
    Expert Opin Investig Drugs; 2000 May; 9(5):1119-27. PubMed ID: 11060732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
    Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
    Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Antithrombin Agents and Factor Xa-Inhibitors in Antithrombotic Treatment.
    Breddin HK
    Turk J Haematol; 2002 Jun; 19(2):113-20. PubMed ID: 27264751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group.
    Verstraete M; Nurmohamed M; Kienast J; Siebeck M; Silling-Engelhardt G; Büller H; Hoet B; Bichler J; Close P
    J Am Coll Cardiol; 1993 Oct; 22(4):1080-8. PubMed ID: 8409044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical potential of oral direct thrombin inhibitors in the prevention and treatment of venous thromboembolism.
    Agnelli G
    Drugs; 2004; 64 Suppl 1():47-52. PubMed ID: 15586627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo thrombin generation and activity during and after intravenous infusion of heparin or recombinant hirudin in patients with unstable angina pectoris.
    Merlini PA; Ardissino D; Rosenberg RD; Colombi E; Agricola P; Oltrona L; Ottani F; Galvani M; Bauer KA; Bottasso B; Bertocchi F; Mannucci PM
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2162-6. PubMed ID: 10978264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.